12/26/2018 New ECF Graduates Bring Their Skills to Egypt & India We at The Eye Cancer Foundation are pleased to celebrate the graduation of our two most recent recent fellows: Dr. Puneet Jain from India and Dr. Moanes Morkos from Egypt. In traditional ECF manner, both fellows return to their country with...
12/10/2018 Free At Last Based on published guidelines from United States Nuclear Regulatory Commission (NRC), The New York Eye Cancer Center and its affiliate New York Eye and Ear Infirmary of Mt. Sinai have agreed that patients undergoing low energy (iodine-125 or palladium-103) eye plaque radiation...
12/05/2018 ECF Fellows Presents: How to Save Eyes in Cairo, Egypt November 22nd Cairo, Egypt: Physician scholars came together for The 2nd Middle East Ophthalmic Oncology & Pediatric Retina Meeting. Organized by Dr. Ihab Othman, the meeting fostered discussion of various topics in ocular oncology...
11/27/2018 Sight-Saving Palladium Radiation Therapy In a recent publication in Cornea: The Journal of Cornea and External Disease, a noteworthy case report describes a patient with squamous cell carcinoma (SCC) in his only functioning eye who had his vision saved using a remarkable application of palladium...
11/20/2018 Oblique (Angled) Injection Technique Improves the Delivery of Avastin Treatment Intravitreal (IVT) injections are the most common surgical procedure in ophthalmology today. In fact, it is projected that millions of these injections are given each year in the United States. Ocular oncologists use...
09/03/2018 NGO in India Promotes World Retinoblastoma Awareness Week Retinoblastoma (RB) is the most common eye cancer in children, affecting approximately 8,000 of them each year. In developed countries like the United States, the survival rate reaches beyond an astounding 96%, with early diagnosis and...
05/31/2018 Understanding Your Data Privacy Whether scrolling through the latest Twitter trends or clearing out your inbox, if you’ve browsed the internet within this past week, the chances are that you have received an influx of emails regarding privacy policy updates from some of your most-frequented websites...
05/17/2018 From India to the Big Apple At the close of 2017, The Eye Cancer Foundation promised its supporters to continue the momentum of the tremendous strides made throughout the year, and indeed it has with yet another Eye Cancer Foundation Ophthalmic Oncology Fellowship thus completed. Meet the...
04/17/2018 The Ocular Tumor Support Group's Next Meeting After several successful meetings throughout the close of 2017, The Ocular Tumor Support Group is back in session! Do you have feelings of loss, stress, anxiety, and/or depression? To be sure, these are all possible experiences people have as they begin to...
03/22/2018 The Global Effort The 2020 Campaign continues to make tremendous strides in the advancement of eye cancer care through the exciting completion of Dr. Milly Shakoor’s 6-month fellowship in retinoblastoma training. This news arrives unitedly with the announcement of another ECF Fellow’s completed training...
03/08/2018 AAO Newsletter Features Paper Published by ECF Fellow From the summer of 2016 to 2017, Dr. Sonal S. Chaugule gained a wealth of knowledge as an Eye Cancer Foundation (ECF) fellow under the tutelage of Dr. Paul T. Finger at the NYECC. From shadowing Dr. Finger’s surgeries at the New York Eye and Ear...
01/24/2018 The 2020 Campaign: Train 20 Specialists in 20 Countries Recognizing the need for international awareness and training in ocular oncology, ECF chairman Dr. Paul T. Finger organized the 2020 Campaign. The campaign was launched in 2016 to ensure that one day, no child has to suffer from metastatic disease...
01/08/2018 ECF Fellow Brings Hope to Bolivia It is with the deepest pride that The Eye Cancer Foundation announces the successful completion of Dr. Veronica Molleda’s first 3-month fellowship in retinoblastoma care at the Hospital Infantil de Mexico. Under the tutelage of Dr. Marco Ramirez...
12/07/2017 New Drug Alert! Patients who have had treatment for a choroidal melanoma with radiation plaque brachytherapy will sometimes go on to develop retinal problems secondary to the radiation exposure which was needed to sterilize their tumor. This is called radiation retinopathy. These retinal problems...
11/09/2017 The NYECC Support Group's Next Meeting! Attend In-Person or via Phone! After two successful meetings where eye cancer patients and survivors shared their feelings in a welcoming, comfortable environment, The New York Eye Cancer Center Support Group, sponsored by The Eye Cancer Foundation...
10/19/2017 The Eye Cancer Foundation's Annual Appeal As the year draws to close, as we round out the end of 2017 with holidays celebrating unity, generosity and love, now comes the time for reflection. The year 2017 marked great, landscaping efforts in the field of eye cancer research and training from The Eye Cancer...
10/06/2017 Plaque Brachytherapy Can Now Help More Patients Facing Enucleation Eye-sparing plaque brachytherapy can now help more patients with uveal melanoma versus enucleation. The American Brachytherapy Society (ABS) reports that more patients with uveal melanoma will be able to spare their...
09/19/2017 Apples or Oranges “Sharing a common scientific language (staging systems) allow us to communicate our ideas and enable progress” writes Dr. Paul T. Finger in Foundational Elements for Collaboration in Ophthalmic Oncology; a recent editorial published for the American Academy...
05/24/2017 ECF Hosts Successful Retinoblastoma Workshop in China Last fall, The Eye Cancer Foundation hosted a retinoblastoma workshop in Guangzhou, China. The primary goal was to deliver systematic training in retinoblastoma management based on the general principles of the origin and development of the disease...
04/20/2017 New Treatment Options for Patients with Radiation Macular Degeneration A recent study published in the British Journal of Ophthalmology and supported by The Eye Cancer Foundation introduces a new treatment option for patients with radiation macular degeneration that no can no longer be...
